Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 23:105:adv43329.
doi: 10.2340/actadv.v105.43329.

Successful Control of Refractory Hidradenitis Suppurativa with Spesolimab: A Case Report

Yangfan Lai #  1 , Yanzhuo Hu #  1 , Xiaoyao Fan  1 , Baishuang Yue  1 , Ying Ma  2
Affiliations

Successful Control of Refractory Hidradenitis Suppurativa with Spesolimab: A Case Report

Yangfan Lai et al. Acta Derm Venereol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Clinical response to spesolimab. (A) Pretreatment clinical image of the axillae. (B) Post-treatment clinical image on Day 14. (C) Posttreatment clinical image on Day 28. (D) Posttreatment clinical image on Day 56.
Fig. 2
Fig. 2
Cytokine concentrations throughout the treatment period. Trends in inflammation and NETs-related biomarkers in patient serum detected by ELISA.
See this image and copyright information in PMC

References

    1. Krueger JG, Frew J, Jemec GBE, Kimball AB, Kirby B, Bechara FG, et al. Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape. Br J Dermatol 2024; 190: 149–162. 10.1093/bjd/ljad345 - DOI - PubMed
    1. Zouboulis CC, Bechara FG, Fritz K, Goebeler M, Hetzer FH, Just E, et al. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version. J Dtsch Dermatol Ges 2024; 22: 868–889. 10.1111/ddg.15412 - DOI - PubMed
    1. McCarthy S. Hidradenitis suppurativa. Annu Rev Med 2025; 76: 69–80. 10.1146/annurev-med-051223-031234 - DOI - PubMed
    1. Zouboulis CC, Frew JW, Giamarellos-Bourboulis EJ, Jemec GBE, Del Marmol V, Marzano AV, et al. Target molecules for future hidradenitis suppurativa treatment. Exp Dermatol 2021; 30: 8–17. 10.1111/exd.14338 - DOI - PubMed
    1. Ogawa Y, Muto Y, Kinoshita M, Shimada S, Kawamura T. Neutrophil extracellular traps in skin diseases. Biomedicines 2021; 9: 1888. 10.3390/biomedicines9121888 - DOI - PMC - PubMed

LinkOut - more resources